Last reviewed · How we verify
NCT03518541
Controlling Femoral Derotation Osteotomy In Cerebral Palsy With Electromagnetic Tracking
NA trial testing Femoral Derotation Osteotomy (FDO) in Gait Disorders, Neurologic in 30 participants. Status unknown.
30 June 2021
Quick facts
| Lead sponsor | Heidelberg University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 December 2017 |
| Primary completion | 30 June 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Femoral Derotation Osteotomy (FDO)
Conditions studied
- Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Malalignment — all drugs for Malalignment →
Sponsor
Heidelberg University
Who can join
Adults 6 to 40, any sex, with Gait Disorders, Neurologic or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is designed to evaluate the use of electromagnetic tracking in transversal plane femoral derotation osteotomies. The goal is to raise the precision of the surgical procedure in order to improve the outcome in short- and long term. All patients are examined with an instrumented 3D gait analysis pre- and one year postoperatively. The electromagnetic tracking system is evaluated against a base line CT or MRI scan serving as reference standard pre- and postoperatively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03518541
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gait Disorders, Neurologic
Currently open trials in the same condition.
- NCT07118228 — Ultrasonographic Assessment of Muscle Morphology, Function, and Clinical Findings in Spastic Cerebral Palsy · recruiting
- NCT07358338 — Application of Device-based Training to Improve Postural Control in Older Adults With CCI · NA · active not recruiting
- NCT06906276 — Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes · recruiting
- NCT06593184 — Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients · NA · recruiting
- NCT07073287 — Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients · Phase 2 · recruiting
Other Heidelberg University trials
Trials by the same sponsor.
- NCT07106294 — Hyperspectral Imaging for Prediction of Preeclampsia · recruiting
- NCT06651164 — Psychosomatic Risk Screening · NA · completed
- NCT07378345 — Optimization of Communication Between Surgery and Pathology · NA · completed
- NCT06018272 — Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany · NA · recruiting
- NCT06852599 — Long-term Outcomes of Implants in Patients with Periodontitis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03518541 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heidelberg University
- Last refreshed: 2 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03518541.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing